News Category: E-Newsletters

TOPICS COVERED IN THIS ISSUE:

• Valuing Economic Loss for Realtors in the Current Realty Market
• Discount Rate Increases to 1.1% for Trials in 2025
• Approaches to Value Customer – Related Intangibles
• Quality of Earnings Reports – What They Are and Why They Matter

TOPICS COVERED IN THIS ISSUE INCLUDE:

• Tax Tidbits
• Corporate Tax Return Filed Late: Ability to get a Tax Refund
• Shareholder Purchasing Asset: Input Tax Credit (ITC)
• Psychotherapy and Counselling Therapy: GST/ HST?

TOPICS COVERED IN THIS ISSUE:

• Normalizing Earnings or Cash Flow
• Consequences of Emigration of a Canadian Taxpayer
• Life Insurance: Do I Really Need it?
• US Tax Issues for US Citizens and Green Card Holders Living in Canada
• Disbursement Quota

TOPICS COVERED IN THIS ISSUE INCLUDE:

• Tax Tidbits
• Real Estate: CRA Audit Activity
• Business Receipts: What is Sufficient?
• Crypto-Assets: Reviews and Audits

TOPICS COVERED IN THIS ISSUE INCLUDE:

• Tax Tidbits
• Capital Gains Inclusion Rate: Proposed Increase
• GST/HST Returns: Mandatory Electronic Filing
• Director Liability: De Facto Director

TOPICS COVERED IN THIS ISSUE:

• Normalizing Earnings or Cash Flow
• FSAT Services
• Unlocking the Value: Understanding Intangible Assets in Business Valuation
• Determining the Economic Benefits of Customer-related Intangible Assets

TOPICS COVERED IN THIS ISSUE:

• The Tax Free Savings Account
• Expense Claims that Pass the Audit Test
• Minority Shareholdings Does a Minority Discount Apply?
• Have you Considered the Scientific Research and Experimental Development Tax Credit?
• Association and HST

TOPICS COVERED IN THIS ISSUE INCLUDE:

• Tax Tidbits
• New Trust Reporting: Unexpected Exposure
• T-Slips: Filing and distribution Issues
• Working from Home Expenses: Employment Expenses

TOPICS COVERED IN THIS ISSUE:

• 2023 Year-end Planning
• 2023 Remuneration

TOPICS COVERED IN THIS ISSUE:

• Minority Shareholdings – Does a Minority Discount Apply?
• CBVs and Legal Matters
• Discount Rate Increases to 1.0% for Trials in 2024